Bicyclic compounds for use as RIP1 kinase inhibitors
US11673892B2 · kind B2 · utility
0Cited by
2References
29Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 9, 2020 |
| Grant date | Jun 13, 2023 |
| Priority date | — |
| Expiry date | Apr 9, 2040 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07B2200/05
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The invention provides novel compounds having the general formula I: or pharmaceutically acceptable salts thereof, wherein RA, RB1, RB2, the A ring and the B ring are as described herein, pharmaceutical compositions including the compounds, and methods of using the compounds.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.